Menu
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Bavarian Nordic Adopting Veeva CRM and Veeva Vault PromoMats for Digital Launch of New Vaccines
Bavarian Nordic Adopting Veeva CRM and Veeva Vault PromoMats for Digital Launch of New Vaccines


Veeva Systems (NYSE: VEEV) today announced that Bavarian Nordic is adopting multichannel Veeva CRM and Veeva Vault PromoMats for the digital launch of new products in the U.S. and Europe, including

Bavarian Nordic Adopting Veeva CRM and Veeva Vault PromoMats for Digital Launch of New Vaccines
Bavarian Nordic Adopting Veeva CRM and Veeva Vault PromoMats for Digital Launch of New Vaccines


Veeva Systems (NYSE: VEEV) today announced that Bavarian Nordic is adopting multichannel Veeva CRM and Veeva Vault PromoMats for the digital launch of new products in the U.S. and Europe, including

Veeva kooperiert im Bereich Biowissenschaften, um eine branchenweite Informationsquelle für Schlüsselkontakte, Informationen und Dienstleistungen firmen- und markenübergreifend anzubieten
Veeva kooperiert im Bereich Biowissenschaften, um eine branchenweite Informationsquelle für Schlüsselkontakte, Informationen und Dienstleistungen firmen- und markenübergreifend anzubieten


Um medizinischen Fachkräften (Healthcare Professionals, HCPs) zu helfen, Anbieter- und Patientenressourcen schneller zu erhalten, stellte Veeva Systems (NYSE:VEEV) heute in Partnerschaft mit der

Dexcom Reports Third Quarter 2020 Financial Results: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Reports Third Quarter 2020 Financial Results


DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2020.



Third Quarter 2020 Financial Highlights:




  • Revenue grew 26% versus the same

Agreement with UCHealth Expands Humana’s Medicare Advantage Provider Network in the Rocky Mountain Region : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Agreement with UCHealth Expands Humana’s Medicare Advantage Provider Network in the Rocky Mountain Region


UCHealth and Humana Inc. (NYSE: HUM), a leading health and well-being company, have signed an in-network agreement for UCHealth University of Colorado Hospital on the Anschutz Medical Campus in

Veeva Teams with Life Sciences to Offer Industrywide Source for Key Contacts, Information, and Services from Across Companies and Brands
Veeva Teams with Life Sciences to Offer Industrywide Source for Key Contacts, Information, and Services from Across Companies and Brands


To help healthcare professionals (HCPs) get provider and patient resources faster, Veeva Systems (NYSE: VEEV), in partnership with the industry, today introduced MyVeeva for Doctors, a mobile

Veeva Teams with Life Sciences to Offer Industrywide Source for Key Contacts, Information, and Services from Across Companies and Brands
Veeva Teams with Life Sciences to Offer Industrywide Source for Key Contacts, Information, and Services from Across Companies and Brands


To help healthcare professionals (HCPs) get provider and patient resources faster, Veeva Systems (NYSE:VEEV), in partnership with the industry, today introduced MyVeeva for Doctors, a mobile

PFIZER REPORTS THIRD-QUARTER 2020 RESULTShttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
PFIZER REPORTS THIRD-QUARTER 2020 RESULTS


Pfizer Inc. (NYSE: PFE) reported financial results for third-quarter 2020 and updated and tightened certain components of Total Company(3) 2020 financial guidance, which continues to reflect actual

FDA Grants Priority Review and EMA Accepts Regulatory Submission for Pfizer’s Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and Up with Moderate to Severe Atopic Dermatitishttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
FDA Grants Priority Review and EMA Accepts Regulatory Submission for Pfizer’s Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and Up with Moderate to Severe Atopic Dermatitis


Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) accepted for filing and granted Priority Review designation to the company’s New Drug Application (NDA) for

Dexcom Announces Retirement of Rick Doubleday and Pre-Announcement of Third Quarter 2020 Revenue: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Retirement of Rick Doubleday and Pre-Announcement of Third Quarter 2020 Revenue


DexCom, Inc. (NASDAQ:DXCM) today announced that Rick Doubleday, Executive Vice President and Chief Commercial Officer, will retire at the end of 2020 in order to spend more time with his family

PerkinElmer erhält CE-Kennzeichnung für auf Atemwegsinfektionen, einschließlich COVID-19, ausgerichtetes Multi-Analyt-Panel: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer erhält CE-Kennzeichnung für auf Atemwegsinfektionen, einschließlich COVID-19, ausgerichtetes Multi-Analyt-Panel


PerkinElmer, Inc. (NYSE: PKI) meldete heute, dass sein PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel die Zulassung für die Vermarktung als In-vitro-Diagnostikum (IVD) in mehr als 30 Ländern im Sinne

Bayer kauft Asklepios: Wird jetzt alles besser?
Bayer kauft Asklepios: Wird jetzt alles besser?

Schon seit vielen Monaten steht die Aktie des Leverkusener Chemie- und Pharmagiganten Bayer (WKN: BAY001) unter Abgabedruck. Grund hierfür ist natürlich die leider völlig verkorkste

PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19 : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19


PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic (IVD) device in more than 30

PerkinElmer Board Declares Quarterly Dividend: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer Board Declares Quarterly Dividend


The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock October 22, 2020. This dividend is payable on February 12, 2021 to

Humana, Quantified Ventures, and Volunteers of America Partner to Establish First of Its Kind Health Outcomes Fund: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana, Quantified Ventures, and Volunteers of America Partner to Establish First of Its Kind Health Outcomes Fund


Humana Inc. (NYSE: HUM) today re-confirms its commitment to provide innovative models of care for families through a catalytic investment of $5 million in an outcomes-based fund, supported by

University Medical Center and Humana Sign Agreement, Expanding Humana’s Medicare Advantage Provider Network in New Orleans : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
University Medical Center and Humana Sign Agreement, Expanding Humana’s Medicare Advantage Provider Network in New Orleans


University Medical Center New Orleans, a part of LCMC Health, and Humana Inc. (NYSE: HUM), a leading health and well-being company, have signed an in-network agreement, expanding access to care for

Humana Joins Forces with DAV (Disabled American Veterans): http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Joins Forces with DAV (Disabled American Veterans)


Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, has entered into an agreement with DAV (Disabled American Veterans), an organization whose mission is

Data From Pfizer’s Adult and Pediatric Clinical Trial Programs for 20-Valent Pneumococcal Conjugate Vaccine Presented at IDWeek 2020http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Data From Pfizer’s Adult and Pediatric Clinical Trial Programs for 20-Valent Pneumococcal Conjugate Vaccine Presented at IDWeek 2020


Pfizer Inc. (NYSE:PFE) today announced the full analysis from one of its Phase 3 studies (NCT03760146), which evaluated the safety and immunogenicity of its 20-valent pneumococcal conjugate vaccine

Chief Medical Officers from Boston Scientific, Illumina, Johnson & Johnson, and QIAGEN to Keynote Veeva MedTech Summit Online
Chief Medical Officers from Boston Scientific, Illumina, Johnson & Johnson, and QIAGEN to Keynote Veeva MedTech Summit Online


Veeva Systems (NYSE: VEEV) today announced the featured keynote speakers at 2020 Veeva Medical Device & Diagnostics Summit Online. Chief medical officers from Boston Scientific, Illumina, Johnson &amp

Quidel to Hold Third Fiscal Quarter 2020 Financial Results Conference Call on October 29th, 2020
Quidel to Hold Third Fiscal Quarter 2020 Financial Results Conference Call on October 29th, 2020


Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report third fiscal quarter 2020 financial

Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020
Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020


Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260, and 1290 Infinity II LC product families have received the My Green Lab accountability, consistency, and transparency

Agilent Vaya Raman Raw Material ID Verification System Receives 2020 R&D 100 Award
Agilent Vaya Raman Raw Material ID Verification System Receives 2020 R&D 100 Award


Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Vaya Raman raw material identity verification system has received a 2020 R&D 100 Award in the Analytical/Test category. The

Humana Announces Major Tennessee Expansion, Will Sell Medicare Advantage Plans in 31 More Counties: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Announces Major Tennessee Expansion, Will Sell Medicare Advantage Plans in 31 More Counties


As part of Humana Inc.’s (NYSE: HUM) major Tennessee expansion in 2021, the leading health and well-being company announced today it is introducing a new Medicare Advantage Health Maintenance

Waters ACQUITY PREMIER Columns Set a New Standard of Performance for Chromatographic Analyses
Waters ACQUITY PREMIER Columns Set a New Standard of Performance for Chromatographic Analyses


Waters Corporation (NYSE:WAT) today introduced ACQUITY™ PREMIER Columns, a new family of premium sub-2-micron columns featuring MaxPeak™ High Performance Surface (HPS) technology. The columns are

Agilent Early Career Professor Award Presented to Carl DeSelm
Agilent Early Career Professor Award Presented to Carl DeSelm


Agilent Technologies Inc. (NYSE: A) today announced that Carl DeSelm, M.D., Ph.D., has received the 2020 Agilent Early Career Professor Award. Dr. DeSelm is an assistant professor of Radiation